| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIXT | preferred | Other | $5.56M | +10.2M | +261% | $0.55 | 14.1M | 25 Oct 2024 | Direct | F1 |
| transaction | BIXT | preferred | Other | -$500 | -100K | -0.71% | $0.01 | 14M | 25 Oct 2024 | Direct | F2 |
| transaction | BIXT | common | Other | $500 | +500K | $0.00 | 500K | 25 Oct 2024 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The shares were issued as payment for the sale of NDPD Pharma to Bioxytran |
| F2 | A 1:5 exchange Preferred Stock (earlier issued under Section 16b-3) into shares of Common Stock. |